Clinical LLM Performance Improves by >300% When Provided With High-Quality Real-World Evidence in New Precision Medicine Benchmark

Read the release
Logo
  • Solutions
        • Health Systems
          • Pharmacy
          • Research Informatics
          • Value Based Care / Quality
        • Life Sciences
          • Precision Medicine AI/ML
          • HEOR, Medical Affairs, and RWE
          • Research and Development
          • Commercial Analytics
  • Technology
        • Content
          • Alexandria®
        • Automation Solutions
          • Atropos Evidence™ Agent
          • ChatRWD®
          • Green Button®
          • Forge®
        • Data
          • GENEVA OS®
          • Atropos Evidence™ Network
          • Data Quality Scoring
  • About
    • About Us
    • Careers
  • Resources
    • Resource Center
    • Publications
    • Customer Stories
    • News & Media
    • Press Releases
    • Blog
  • Contact Us
  • Login
Atropos Health Partners with Norstella to Expand the Atropos Evidence™ Network and Structured Clinical Trial Intelligence

Atropos Health Partners with Norstella to Expand the Atropos Evidence™ Network and Structured Clinical Trial Intelligence

by a9b1da23_admin | Jun 17, 2024 | Press Release

Through this Partnership, additional Go-To-Market Partners will go live and the Adoption of GENEVA OS™ will Rapidly Expand PALO ALTO, CA – June 17, 2024 –  Atropos Health, the pioneer in translating real-world clinical data into high-quality...
Outsourcing Pharma: How Atropos Health is Transforming the Landscape of Evidence Based Medicine

Outsourcing Pharma: How Atropos Health is Transforming the Landscape of Evidence Based Medicine

by a9b1da23_admin | Mar 28, 2024 | News and Media

See Outsourcing Pharma’s latest piece on using Real-World Data (RWD) to bridge the evidence gap in medicine. Select excerpts below. The lack of diversity in clinical trials contributes to widening health disparities and delaying equitable access to medications and...
Atropos Health Forms Life Science Advisory Board, Increasing Commitment to Accelerated Drug Development and Clinical Trial Diversity and Inclusion

Atropos Health Forms Life Science Advisory Board, Increasing Commitment to Accelerated Drug Development and Clinical Trial Diversity and Inclusion

by a9b1da23_admin | Nov 30, 2023 | Press Release

The life sciences advisory board indicates a continued focus on regulatory complaint and transparent methods for rapid and responsible acceleration of innovation for life science partners on the Atropos Evidence Network PALO ALTO, CA – Nov.  30, 2023 (Business...
Next Entries »
DiviWP Logo
  • Follow
  • Follow

Solutions

Health Systems

Pharmacy

Research Informatics

Value Based Care / Quality

GME

Life Sciences

Precision Medicine AI/ML

HEOR, Medical Affairs & RWE

Research & Development

Commercial Analytics

Technology

Content

Alexandria®

Automation Solutions

Atropos Evidence™ Agent

ChatRWD®

Green Button®

Forge®

Data

GENEVA OS®

Atropos Evidence™ Network

Data Quality Scoring

About

  • About Us
  • Careers

Resources

  • Resources Center
  • Publications
  • Customer Stories
  • News & Media
  • Press Releases
  • Blog

Copyright © 2026 Atropos Health. All Rights Reserved | Privacy Policy | Ethics Report | Terms of Service

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}